U.S., April 2 -- ClinicalTrials.gov registry received information related to the study (NCT06904456) titled 'Advanced HIV Disease During the First Six Months on Antiretroviral Therapy in Zambia' on March 23.

Brief Summary: In Zambia, an estimated 20% of HIV-positive clients continue to present for first-time antiretroviral therapy (ART) initiation or re-initiation with advanced HIV disease (AHD). The Zambia Ministry of Health (MOH) and other key stakeholders lack information about the characteristics and behaviors of AHD clients, including how they are defined and diagnosed (e.g. low CD4 count v. clinical condition), their demographic and socioeconomic profiles, their HIV care histories, what services they receive, and their short-term out...